Olsen, Christina Kurre

A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder

Katona, C., Hansen, T., & Olsen, C. K. (2012) · International Clinical Psychopharmacology

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 445

A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults

McIntyre, R. S., Lophaven, S., & Olsen, C. K. (2014) · The International Journal of Neuropsychopharmacology

Treatment of Major DepressionSchizophrenia research and treatment

Cited by 433

Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day: a randomized, double-blind, placebo-controlled, duloxetine-referenced study in the acute treatment of adult patients with major depressive disorder

Boulenger, J.-P., Loft, H., & Olsen, C. K. (2014) · International Clinical Psychopharmacology

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 176

The effects of vortioxetine on cognitive dysfunction in patients with inadequate response to current antidepressants in major depressive disorder: A short-term, randomized, double-blind, exploratory study versus escitalopram

Vieta, E., Sluth, L. B., & Olsen, C. K. (2018) · Journal of Affective Disorders

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 72

Which cognitive domains are improved by treatment with vortioxetine?

Harrison, J. E., Lophaven, S., & Olsen, C. K. (2016) · International Journal of Neuropsychopharmacology

Treatment of Major DepressionSchizophrenia research and treatment

Cited by 59